Professor of Health Economics in the Division of Health Research at Lancaster University, United Kingdom. She holds a PhD in Public Health-Health Economics from the National School of Public Health, Nova University of Lisbon in Portugal, an MSc in European Social Policy Analysis from Bath University in the UK, and graduated in Economics from ISEG – Lisbon School of Economics and Management, Lisbon University in Portugal. Between 2001 and 2014 she was Assistant Professor of Health Economics at the National School of Public Health at University Nova of Lisbon. She worked for the Institute of Management and IT (Ministry of Health) in the Department of Information Systems Development from 1995 until 2000, where she was the Executive responsible for the Financing System/Classification System in Diagnoses Related Groups. She has over 25 years of experience in research and has developed her expertise around economic evaluation of health technologies and interventions, efficiency measurement, equity and quality of life. She has been involved in several scientific associations in the field of health care such as PCSI (Patient Classification Systems international (pcsinternational.org), where she was President between 2000 and 2009), EuHEA (European Health Economics Association: Home - EuHEA) and the Portuguese Chapter of ISPOR (The Professional Society for Health Economics and Outcomes Research: ISPOR - Home). She was the President of the Portuguese Health Economics Association between 2017-2023. Currently she is President Elect for EuHEA.
Expert in the Appraisals Committee of Infarmed, the Portuguese National Authority of Medicines and Health Products.
In 2019 she was one of the experts invited to author the update of the Portuguese Guidelines for Economic Evaluation of Health Technologies. These Guidelines are now published as a Law Ordinance Portaria nº391/2019, 30th October - text in Portuguese can be found here; https://dre.pt/application/conteudo/125815921
